| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/19/2004 | DE10304950A1 Herstellung von Tetrahydrochinolinbenzofuranen Production of Tetrahydrochinolinbenzofuranen |
| 08/19/2004 | DE10304870A1 Triazolverbindungen und ihre therapeutische Verwendung Triazole compounds and their therapeutic use |
| 08/19/2004 | DE10237722A1 Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase Indole or benzimidazole derivatives for the modulation of IkappaB kinase |
| 08/19/2004 | CA2515717A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |
| 08/19/2004 | CA2514703A1 Use of the sgk gene family for diagnosis and therapy of cataracts and glaucoma |
| 08/19/2004 | CA2514510A1 Polymer conjugates of mutated neublastin |
| 08/19/2004 | CA2513824A1 Saturated quinoxaline derivatives and their use as metabotropic glutamate receptor ligands |
| 08/19/2004 | CA2513722A1 Active immunization to generate antibodies to soluble a-beta |
| 08/19/2004 | CA2513631A1 Cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors |
| 08/19/2004 | CA2513409A1 Pyrazolo`1,5-a!`1,3,5!triazine derivatives as cannabinoid receptor ligands |
| 08/19/2004 | CA2512514A1 Benzo (1,2,5) thiadiazole als crf-antagonisten |
| 08/18/2004 | EP1447407A1 Adenosine derivatives |
| 08/18/2004 | EP1447402A1 Quinoline compound |
| 08/18/2004 | EP1447401A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient |
| 08/18/2004 | EP1447400A1 Bicyclic compound |
| 08/18/2004 | EP1447399A1 "2-oxo-1-pyrrolidine derivative and its pharmaceutical uses" |
| 08/18/2004 | EP1447093A1 Inhibition of the CD95 ligand/receptor system for the treatment of neurological disorders and injuries |
| 08/18/2004 | EP1446733A2 Glycosylphosphatidylinositol containing polypeptides |
| 08/18/2004 | EP1446500A2 A method for regulating immune function in primates using the foxp3 protein |
| 08/18/2004 | EP1446487A1 Mammalian protein phosphatases |
| 08/18/2004 | EP1446419A2 Therapeutic polypeptides, nucleic acids encoding the same, and methods of use |
| 08/18/2004 | EP1446407A2 (pyrido/thieno)-(f)-oxazepin-5-one derivatives as positive modulators of the ampa receptor |
| 08/18/2004 | EP1446402A1 2-amino-4-heteroarylethyl thiazoline derivatives and their use an inhibitors of inducible no-synthase |
| 08/18/2004 | EP1446400A1 Piperidine derivatives, process for preparation thereof, and pharmaceutical composition for alzheimer's disease containing the same |
| 08/18/2004 | EP1446399A1 Piperazine derivatives having sst1 antagonistic activity |
| 08/18/2004 | EP1446397A1 Novel mandelate salts of substituted tetracyclic tetrahydrofuran derivatives |
| 08/18/2004 | EP1446396A1 Methods for treating depression and other cns disorders using enantiomerically enriched desmethyl- and didesmethyl-metabolites of citalopram |
| 08/18/2004 | EP1446394A1 NOVEL 1,2,4−THIADIAZOLE DERIVATIVES AS MELANOCORTIN RECEPTOR MODULATORS |
| 08/18/2004 | EP1446393A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
| 08/18/2004 | EP1446387A1 Substituted aryl 1,4-pyrazine derivatives |
| 08/18/2004 | EP1446385A1 Preparation and use of substituted imidazoles |
| 08/18/2004 | EP1446383A1 Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain |
| 08/18/2004 | EP1446379A1 Aryl aniline beta-2 adrenergic receptor agonists |
| 08/18/2004 | EP1446143A2 Use of obg3 for promoting central nervous system remyelination |
| 08/18/2004 | EP1446135A1 Standardized extracts of scutellaria lateriflora |
| 08/18/2004 | EP1446133A2 Methods of improving central nervous system functioning |
| 08/18/2004 | EP1446129A2 Polynucleotide therapy |
| 08/18/2004 | EP1446127A1 Triazepine derivatives as neurotrophic agents |
| 08/18/2004 | EP1446125A1 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity |
| 08/18/2004 | EP1446123A1 Rosuvastatin in pre demented states |
| 08/18/2004 | EP1446122A1 Use of flibanserin in the treatment of sexual disorders |
| 08/18/2004 | EP1446115A2 Cyanoalkylamino derivatives as protease inhibitors |
| 08/18/2004 | EP1446113A2 Compounds and methods for treating transplant rejection |
| 08/18/2004 | EP1446110A2 Organosulfur inhibitors of tyrosine phosphatases |
| 08/18/2004 | EP1446107A1 Process for the preparation of tablets comprising s-adenosylmethionine |
| 08/18/2004 | EP1446104A1 Spray drying methods and compositions thereof |
| 08/18/2004 | EP1446100A2 Injectable depot compositions and uses thereof |
| 08/18/2004 | EP1446088A2 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process |
| 08/18/2004 | EP1446045A2 An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
| 08/18/2004 | EP1446015A1 Remodeling of tissues and organs |
| 08/18/2004 | EP1446008A2 Compositions and methods for controlled release |
| 08/18/2004 | EP1315504B1 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
| 08/18/2004 | EP1252170B1 Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate |
| 08/18/2004 | EP1212309B1 Caspase inhibitor |
| 08/18/2004 | EP1194426B1 Benzofurane derivatives |
| 08/18/2004 | EP1187814B1 5-phenyl-pyrimidine derivatives |
| 08/18/2004 | EP1179020A4 Low-dose il-1beta-induced photoreceptor cell rescue without retinal dysplasia |
| 08/18/2004 | EP1140119B1 Use OF LOW MOLECULAR WEIGHT HEPARIN for the prevention and/or treatment of motoneuronal diseases |
| 08/18/2004 | EP1117390B1 Mucosal originated drug delivery systems |
| 08/18/2004 | EP1086082B1 Arylsubstituted olefinic amines and their use as cholinergic receptors agonists |
| 08/18/2004 | EP1030857B1 Adenosine a1 receptor agonists |
| 08/18/2004 | EP1030856B1 Adenosine a1 receptor agonists |
| 08/18/2004 | EP0909171B1 Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1 |
| 08/18/2004 | EP0820507B1 Ndf peptides |
| 08/18/2004 | CN1522258A Novel 4-amino-5,6-substituted thiopheno 2,3-d]pyrimidines |
| 08/18/2004 | CN1522256A Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharamaceutical compositions comprising them and their use as a medicine |
| 08/18/2004 | CN1522254A Immunomodulating compounds |
| 08/18/2004 | CN1522252A Dihydro-benzo(b)(1,4)diazepin-2-one derivatives as mglur2 antagonists I |
| 08/18/2004 | CN1522245A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes |
| 08/18/2004 | CN1522241A Crystalline form of a phenylethanolamine, preparation thereof and pharmaceutical compositions comprising same |
| 08/18/2004 | CN1522155A Method for producing a vaccine |
| 08/18/2004 | CN1522143A Coenzyme q and eicosapentaenoic acid (epa) |
| 08/18/2004 | CN1522142A Potassium channel opener |
| 08/18/2004 | CN1522140A Oxcarbazepine dosage forms |
| 08/18/2004 | CN1522139A Enhanced parmacokinetic profile of hydrophobic substances |
| 08/18/2004 | CN1520867A Medicine for stopping smoking and preparing process thereof |
| 08/18/2004 | CN1520841A Novel pharmaceutical composition and medical uses thereof |
| 08/18/2004 | CN1520840A Novel pharmaceutical composition and medical uses thereof |
| 08/18/2004 | CN1520831A Health-preserving liver-protecting drug and method for making same |
| 08/18/2004 | CN1520828A Sleeping recovery healthcare products |
| 08/18/2004 | CN1520818A Cholinesterase inhibitor pharmaceutical composition for senile dementia |
| 08/18/2004 | CN1520817A Nimodipine slow release capsule and its preparation method |
| 08/18/2004 | CN1520806A Novel use of agmatine |
| 08/18/2004 | CN1520805A Ubiquinone containing composition |
| 08/18/2004 | CN1162432C 2,3-benzodiazepine derivatives |
| 08/18/2004 | CN1162430C High-tension condensed ring nicotine analogue, preparation process and use thereof |
| 08/18/2004 | CN1162425C 4-hydroxyl-piperidine derivative |
| 08/18/2004 | CN1162424C Quinoline-4-yl derivative II |
| 08/18/2004 | CN1162414C Benzothiadiazine derivs., preparation method and pharmaceutical compositions contg. same |
| 08/18/2004 | CN1162168C Brain nourishing oral liquid and its preparing method |
| 08/18/2004 | CN1162156C Use of olanzapine and fluoxetine in preparing medicine for psychosis |
| 08/17/2004 | US6777577 Anticancer agents; antidiabetic agents, anticholesterol agents, cardiovascular disorders, osteoporosis |
| 08/17/2004 | US6777557 Method and composition for rejuvenating cells, tissues organs, hair and nails |
| 08/17/2004 | US6777437 Antidepressants, anxiolytic agents. sexual disorders |
| 08/17/2004 | US6777434 Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 08/17/2004 | US6777430 Phenylsulphonyl derivatives as 5-HT receptor ligands |
| 08/17/2004 | US6777428 Inhibit peptide extravasation due to stimulation of the trigeminal ganglia, and are therefore useful for the treatment of migraine and associated disorders |
| 08/17/2004 | US6777421 Treating a condition selected from the group consisting of anxiety, depression, substance abuse, neuropathic pain, acute pain, migraine, asthma, cough and improved cognition, in a subject in need thereof comprising administering a compound |
| 08/17/2004 | US6777416 Isoxazolo pyrimidinones and the use thereof |
| 08/17/2004 | US6777409 For therapy of inflammation |